A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers

Zachary R. Simoni, Michelle Martin, Jennifer A. Wenzel, Elise D. Cook, Badrinath Konety, Selwyn M. Vickers, Moon S. Chen, Mona N. Foaud, Raegan W. Durant

Research output: Contribution to journalArticle

Abstract

Background: Minority enrollment in cancer clinical trials is traditionally low. In light of this fact, numerous studies have investigated barriers to recruitment and retention within minority populations. However, very little research has investigated the importance of clinicians’ and researchers’ motivations for minority recruitment in cancer clinical trials. Therefore, we sought to examine motivations for minority recruitment across four professional stakeholder groups (principal investigators, clinicians, research staff, and Cancer Center leaders) at five National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. Methods: This study is based on the data from 91 qualitative interviews conducted across the five NCI-designated Comprehensive Cancer Centers to investigate stakeholders’ motivations for minority recruitment in cancer clinical trials. Results: Emergent themes include (a) minority recruitment increases generalizability of cancer clinical trials, (b) minority recruitment is motivated by social justice, (c) some institutions promote minority recruitment through the use of supplemental financial support, (d) federal funding requirements for minority inclusion in clinical research motivate investigators to focus on minority recruitment, and (e) some stakeholders favor a more race-neutral approach to participant recruitment rather than an emphasis on targeted minority recruitment. Conclusion: The perspectives of clinical and research stakeholders potentially inform the assessment of existing strategies and the development of new strategies to increase motivation for minority recruitment in cancer clinical trials.

Original languageEnglish (US)
Pages (from-to)992-998
Number of pages7
JournalJournal of Racial and Ethnic Health Disparities
Volume4
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

National Cancer Institute (U.S.)
cancer
minority
Clinical Trials
Neoplasms
Research Personnel
stakeholder
Research
Financial Support
Social Justice
Interviews
qualitative interview
social justice
funding
inclusion

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Anthropology
  • Sociology and Political Science
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers. / Simoni, Zachary R.; Martin, Michelle; Wenzel, Jennifer A.; Cook, Elise D.; Konety, Badrinath; Vickers, Selwyn M.; Chen, Moon S.; Foaud, Mona N.; Durant, Raegan W.

In: Journal of Racial and Ethnic Health Disparities, Vol. 4, No. 5, 01.10.2017, p. 992-998.

Research output: Contribution to journalArticle

Simoni, Zachary R. ; Martin, Michelle ; Wenzel, Jennifer A. ; Cook, Elise D. ; Konety, Badrinath ; Vickers, Selwyn M. ; Chen, Moon S. ; Foaud, Mona N. ; Durant, Raegan W. / A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers. In: Journal of Racial and Ethnic Health Disparities. 2017 ; Vol. 4, No. 5. pp. 992-998.
@article{dcd2e3bf583a45789c0c3b7ef41c2569,
title = "A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers",
abstract = "Background: Minority enrollment in cancer clinical trials is traditionally low. In light of this fact, numerous studies have investigated barriers to recruitment and retention within minority populations. However, very little research has investigated the importance of clinicians’ and researchers’ motivations for minority recruitment in cancer clinical trials. Therefore, we sought to examine motivations for minority recruitment across four professional stakeholder groups (principal investigators, clinicians, research staff, and Cancer Center leaders) at five National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. Methods: This study is based on the data from 91 qualitative interviews conducted across the five NCI-designated Comprehensive Cancer Centers to investigate stakeholders’ motivations for minority recruitment in cancer clinical trials. Results: Emergent themes include (a) minority recruitment increases generalizability of cancer clinical trials, (b) minority recruitment is motivated by social justice, (c) some institutions promote minority recruitment through the use of supplemental financial support, (d) federal funding requirements for minority inclusion in clinical research motivate investigators to focus on minority recruitment, and (e) some stakeholders favor a more race-neutral approach to participant recruitment rather than an emphasis on targeted minority recruitment. Conclusion: The perspectives of clinical and research stakeholders potentially inform the assessment of existing strategies and the development of new strategies to increase motivation for minority recruitment in cancer clinical trials.",
author = "Simoni, {Zachary R.} and Michelle Martin and Wenzel, {Jennifer A.} and Cook, {Elise D.} and Badrinath Konety and Vickers, {Selwyn M.} and Chen, {Moon S.} and Foaud, {Mona N.} and Durant, {Raegan W.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1007/s40615-016-0303-3",
language = "English (US)",
volume = "4",
pages = "992--998",
journal = "Journal of racial and ethnic health disparities",
issn = "2197-3792",
publisher = "Springer Nature",
number = "5",

}

TY - JOUR

T1 - A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers

AU - Simoni, Zachary R.

AU - Martin, Michelle

AU - Wenzel, Jennifer A.

AU - Cook, Elise D.

AU - Konety, Badrinath

AU - Vickers, Selwyn M.

AU - Chen, Moon S.

AU - Foaud, Mona N.

AU - Durant, Raegan W.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: Minority enrollment in cancer clinical trials is traditionally low. In light of this fact, numerous studies have investigated barriers to recruitment and retention within minority populations. However, very little research has investigated the importance of clinicians’ and researchers’ motivations for minority recruitment in cancer clinical trials. Therefore, we sought to examine motivations for minority recruitment across four professional stakeholder groups (principal investigators, clinicians, research staff, and Cancer Center leaders) at five National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. Methods: This study is based on the data from 91 qualitative interviews conducted across the five NCI-designated Comprehensive Cancer Centers to investigate stakeholders’ motivations for minority recruitment in cancer clinical trials. Results: Emergent themes include (a) minority recruitment increases generalizability of cancer clinical trials, (b) minority recruitment is motivated by social justice, (c) some institutions promote minority recruitment through the use of supplemental financial support, (d) federal funding requirements for minority inclusion in clinical research motivate investigators to focus on minority recruitment, and (e) some stakeholders favor a more race-neutral approach to participant recruitment rather than an emphasis on targeted minority recruitment. Conclusion: The perspectives of clinical and research stakeholders potentially inform the assessment of existing strategies and the development of new strategies to increase motivation for minority recruitment in cancer clinical trials.

AB - Background: Minority enrollment in cancer clinical trials is traditionally low. In light of this fact, numerous studies have investigated barriers to recruitment and retention within minority populations. However, very little research has investigated the importance of clinicians’ and researchers’ motivations for minority recruitment in cancer clinical trials. Therefore, we sought to examine motivations for minority recruitment across four professional stakeholder groups (principal investigators, clinicians, research staff, and Cancer Center leaders) at five National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. Methods: This study is based on the data from 91 qualitative interviews conducted across the five NCI-designated Comprehensive Cancer Centers to investigate stakeholders’ motivations for minority recruitment in cancer clinical trials. Results: Emergent themes include (a) minority recruitment increases generalizability of cancer clinical trials, (b) minority recruitment is motivated by social justice, (c) some institutions promote minority recruitment through the use of supplemental financial support, (d) federal funding requirements for minority inclusion in clinical research motivate investigators to focus on minority recruitment, and (e) some stakeholders favor a more race-neutral approach to participant recruitment rather than an emphasis on targeted minority recruitment. Conclusion: The perspectives of clinical and research stakeholders potentially inform the assessment of existing strategies and the development of new strategies to increase motivation for minority recruitment in cancer clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85013627582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013627582&partnerID=8YFLogxK

U2 - 10.1007/s40615-016-0303-3

DO - 10.1007/s40615-016-0303-3

M3 - Article

VL - 4

SP - 992

EP - 998

JO - Journal of racial and ethnic health disparities

JF - Journal of racial and ethnic health disparities

SN - 2197-3792

IS - 5

ER -